The first two months of 2017 saw a flurry of alliances that involved Asian players, whose partnerships with western counterparts have noticeably risen in recent years. This is driven by companies in the west seeking to expand eastwards into emerging markets, namely China, while Asian companies are looking to bring in innovation developed abroad to meet growing domestic demand for quality health care solutions.
US molecular diagnostics firm Biodesix Inc. has licensed toBeijing Bioyong Technology Co. Ltd. the rights to develop and sell...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?